News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Magellan Biosciences, Inc. and Miacom Diagnostics Team Up to Enable Faster, Easier Identification of Pathogens as Part of Magellan’s End-to-End Suite of Microbiology Products Designed to Streamline Lab Workflow and Enable Better Treatment Decisions


4/15/2011 9:40:06 AM

CHELMSFORD, Mass. & DUESSELDORF, Germany--(BUSINESS WIRE)--Magellan Biosciences, a global manufacturer of products designed to make diagnostic testing easier, more cost-effective, and less labor-intensive, is partnering with Germany-based miacom diagnostics GmbH to bring miacom’s unique, cost-effective family of molecular tests to the U.S. and Canadian markets. The 30-minute tests identify sepsis-related pathogens directly from blood-culture bottles, enhancing Magellan’s suite of blood culture, microbial identification, and susceptibility test products for microbiology laboratories. The combined offering is designed to provide fast, reliable results for laboratories of all sizes, enabling clinicians to make more-informed treatment decisions that improve patient care and help in the global fight against drug resistance.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES